Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

As filed on our From 10-K/A on September 19, 2014, we restated our December 31, 2013 Balance Sheet as it pertains to the Fair Value of our Warrants, Preferred Series C & D and Convertible Debentures to amounts as stated below from how they were reported as of December 31, 2013 in our 10-K (in thousands): 

	December 31, 2013 (as previously reported)		Adjustments		December 31, 2013 (Restated)
Derivative Financial Instruments – warrants	$	684	$	(64)	$	620
Derivative Financial Instruments – Series C and D	$	23,606	$	(23,310)	$	296
Debentures payable – carried at fair value	$	257,451	$	(219,201)	$	38,250
Total Liabilities	$	284,576	$	(242,575)	$	42,001
Accumulated Deficit	$	(479,485)	$	242,575	$	(236,910)
Total shareholders’ deficit	$	(284,435)	$	242,575	$	(41,860)

Schedule of Derivative Instruments [Table Text Block]

The table below reflects the changes in restating the statement of operations for the year ended December 31, 2013 (in thousands):

	Year Ended December 31, 2013 (as previously reported)		Adjustments		Year Ended December 31,  2013  (Restated)
Gain (loss) from change in fair value of hybrid financial instruments	$	(197,392)	$	219,201	$	21,809
Gain (loss) from change in fair value of derivative liability – warrants	$	3,003	$	64	$	3,067
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(21,469)	$	23,310	$	1,841
Net income (loss) before taxes	$	(214,819)	$	242,575	$	27,756
Net income (loss)	$	(214,113)	$	242,575	$	28,462
Net income (loss) available to common shareholders	$	(214,855)	$	242,575	$	27,720
Comprehensive income (loss)	$	(213,980)	$	242,575	$	28,595

Schedule of Derivative Instruments in Statement of Cash Flows, Fair Value [Table Text Block]

Statement of Cash Flow:

	Year Ended December 31, 2013 (as previously reported)		Adjustments		Year Ended December 31, 2013  (Restated)
Net income (loss)	$	(214,113)	$	242,575	$	28,462
Gain (loss) from change in fair value of hybrid financial instruments	$	(197,392)	$	219,201	$	21,809
Gain (loss) from change in fair value of derivative liability – warrants	$	3,003	$	64	$	3,067
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(21,469)	$	23,310	$	1,841
Net cash used in operating activities	$	(399)	$	-	$	(399)

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following is a reconciliation of the numerator and denominator of the basic and diluted net loss or gain per share calculations for each period (in thousands, except share and per share data):

	Year Ended December 31,
	2014		2013  (Restated)
Basic loss per common share:
Numerator: (Net loss) gain available to common shareholders	$	(2,467)	$	27,720
Denominator: Weighted average shares outstanding		1,585,816,122		274,625,840
Basic loss per common share	$	(0.000)	$	(0.100)
Diluted loss per common share:
Numerator:
Net loss available to common shareholders	$	(2,467)	$	27,720
Effect of dilutive securities		-		-
Diluted net loss available to common shareholders	$	(2,467)	$	-
Denominator:
Weighted average shares outstanding		1,585,816,122		274,625,840
Effect of dilutive securities		-		-
Diluted weighted average shares outstanding		-		274,625,840
Diluted loss per common share	$	(0.000)	$	0.10

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The following table reflects the outstanding stock options, warrants, convertible debt and convertible preferred securities as of December 31, 2014 and 2013, which have been excluded from the diluted loss per common share calculation because inclusion of the securities would be anti-dilutive:

	December 31,
	2014		2013
Stock options		-		1,173,020
Warrants		499,990,063		499,990,063
Convertible debt		234,287,861,850		234,287,861,850
Convertible preferred stock		26,617,345,361		26,617,345,361
		261,405,197,274		261,406,370,294

Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]

The fair value measurements for the Company's liabilities measured at fair value on a recurring basis as of December 31, 2014 and 2013 as follows:

	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Gain (Losses)
December 31, 2014:
Derivative Financial Instruments - Warrants		2,000		-		-		2,000		618,000
Derivative Financial Instruments - Series D & C preferred stock		6,000		-		-		6,000		289,000
Debentures Payable Carried at fair value		37,384,000		-		-		37,384,000		(4,173,000)
Total		37,392,000		-		-		37,392,000		(3,266,000)
December 31, 2013:
Derivative Financial Instruments - Warrants		620,000		-		-		620,000		3,067,000
Derivative Financial Instruments - Series D & C preferred stock		296,000		-		-		296,000		1,841,000
Debentures Payable Carried at fair value		38,250,000		-		-		38,250,000		21,809,000
Total		39,166,000		-		-		39,166,000		26,717,000
Following is a reconciliation for Level 3 liabilities measured on a recurring basis:
December 31, 2014										37,392,000
Gain from change in fair value of derivative liability - warrants										618,000
Gain from change in fair value of derivative liability - Series C & D preferred stock and Debentures										289,000
Loss from change in fair value of hybrid financial instruments										(4,173,000)
Gain on extinguishment of debt										4,247,000
Conversion of debentures to common stock										793,000
December 31, 2013										39,166,000
December 31, 2013										39,166,000
Gain from change in fair value of derivative liability - warrants										3,067,000
Gain from change in fair value of derivative liability - Series C & D preferred stock and Debentures										1,841,000
Gain from change in fair value of hybrid financial instruments										21,809,000
Conversion of debentures to common stock										4,243,000
December 31, 2012										70,126,000

Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]

The fair value measurements for the Company’s assets measured at fair value on a nonrecurring basis as of December 31, 2014 and 2013 follows:

	Total		Quoted  Prices in  Active  Markets for  Identical  Assets  (Level 1)		Significant  Other  Observable  Inputs  (Level 2)		Significant  Unobservable  Inputs  (Level 3)		Total Gains  (Losses)
December 31, 2014:
Goodwill	$	—	$	—	$	—	$	—	$	(3,418,000)
December 31, 2013:
Goodwill	$	3,418,000	$	—	$	—	$	3,418,000	$	—

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets are amortized, using the straight-line method, over the estimated period of benefit as noted below:

Capitalized patents	5 - 17 years
Acquired software products	7 years

Property, Plant and Equipment [Table Text Block]

Depreciation is recorded on a straight-line basis over the estimated useful lives of the assets as noted below:

Furniture and fixtures	3 - 7 years
Equipment	2 - 5 years